Results 331 to 340 of about 849,024 (375)
Some of the next articles are maybe not open access.
Replication of hepatitis C virus
Nature Reviews Microbiology, 2007Exciting progress has recently been made in understanding the replication of hepatitis C virus, a major cause of chronic hepatitis, liver cirrhosis and hepatocellular carcinoma worldwide. The development of complete cell-culture systems should now enable the systematic dissection of the entire viral lifecycle, providing insights into the hitherto ...
Darius Moradpour, François Penin
exaly +5 more sources
Annals of Internal Medicine, 2016 This issue provides a clinical overview of hepatitis C virus, focusing on transmission, prevention, screening, diagnosis, evaluation, and treatment. The content of In the Clinic is drawn from the clinical information and education resources of the American College of Physicians (ACP), including MKSAP (Medical Knowledge and Self-Assessment Program ...
Jake Liang, Christopher Koh, Qisheng Li
openaire +3 more sources
Nursing Clinics of North America, 2004
Hepatitis C virus is a common blood-borne pathogen that is now declining as a new infection in the population. However, women and men who were infected 2 to 3 decades ago are now developing liver damage. To prevent further damage, treatment with IFN and ribavirin is available.
Monica Jarrett, Paula P. Cox
openaire +3 more sources
Hepatitis C virus is a common blood-borne pathogen that is now declining as a new infection in the population. However, women and men who were infected 2 to 3 decades ago are now developing liver damage. To prevent further damage, treatment with IFN and ribavirin is available.
Monica Jarrett, Paula P. Cox
openaire +3 more sources
Antibodies to hepatitis C virus and hepatitis C virus infection
Gastroenterologia Japonica, 1993The authors studied the interrelationship of antibody to hepatitis C virus core protein (anti-HCV core), antibody to C100-3 antigen (anti-C100-3) and serum hepatitis C virus RNA positivity in chronic liver disease patients. Anti-HCVcore was detected with high titers in 95% (69/73) of chronic non-A, non-B hepatitis patients, while anti-C100-3 was found ...
Norio Hayashi +5 more
openaire +3 more sources
Annals of Internal Medicine, 2020
Hepatitis C virus (HCV) is the most common bloodborne pathogen in the United States, chronically affecting approximately 2.4 million Americans, most of whom are unaware of the infection. Highly effective, well-tolerated therapies are now available with markedly simplified treatment algorithms. Eradication of HCV is a national goal. Increased efforts to
openaire +3 more sources
Hepatitis C virus (HCV) is the most common bloodborne pathogen in the United States, chronically affecting approximately 2.4 million Americans, most of whom are unaware of the infection. Highly effective, well-tolerated therapies are now available with markedly simplified treatment algorithms. Eradication of HCV is a national goal. Increased efforts to
openaire +3 more sources
Heterogeneity of hepatitis C virus
Baillière's Clinical Gastroenterology, 1996A great deal of information on the molecular heterogeneity of hepatitis C virus (HCV) has been achieved since its discovery in 1989. However, little is known about the clinical significance of these variations. Based on the degree of sequence variation, HCV has been classified into six major groups or types, differing by 31-34% at the nucleotide level ...
SMITH D, PONTISSO, PATRIZIA
openaire +4 more sources
Hepatitis C virus risk: a hepatitis C virus related syndrome
Journal of Internal Medicine, 2000Abstract. Mazzaro C, Panarello G, Tesio F, Santini G, Crovatto M, Mazzi G, Zorat F, Tulissi P, Pussini E, Baracetti S, Campanacci L, Pozzato G (Pordenone General Hospital, Pordenone; University of Trieste, School of Medicine, Trieste, Italy). Hepatitis C virus risk: a hepatitis C virus‐related syndrome. J Intern Med 2000 247: 535–545.Background.
S. Baracetti +11 more
openaire +3 more sources